drugset / Trial / NCT04914520

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

NCT04914520 ↗

Phase 1 Completed 48 enrolled Daiichi Sankyo
RandomizedParallel-groupTriple-blindPrevention

Summary

This study will assess the safety, tolerability, and immunogenicity of VN-0200 after intramuscular injections in Japanese healthy adults and elderly subjects.

Timeline

Start
2021-06-11
Primary completion
2021-12-16
Completion
2021-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject VN-0200 Vaccine — Intramuscular